vs
Side-by-side financial comparison of BADGER METER INC (BMI) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
BADGER METER INC is the larger business by last-quarter revenue ($234.1M vs $185.2M, roughly 1.3× AMICUS THERAPEUTICS, INC.). BADGER METER INC runs the higher net margin — 14.3% vs 0.9%, a 13.4% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 14.1%). BADGER METER INC produced more free cash flow last quarter ($50.8M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 9.2%).
Badger Meter Inc. is a leading global provider of flow measurement and control solutions, serving water utilities, industrial, commercial, and residential customer segments. Its core offerings include smart water meters, IoT-enabled usage monitoring systems, and supporting software that help clients track resource consumption, cut waste, and boost operational efficiency, with key markets spanning North America, Europe, and the Asia-Pacific region.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
BMI vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $234.1M | $185.2M |
| Net Profit | $33.6M | $1.7M |
| Gross Margin | 39.7% | 85.7% |
| Operating Margin | 18.4% | 8.6% |
| Net Margin | 14.3% | 0.9% |
| Revenue YoY | 14.1% | 23.7% |
| Net Profit YoY | 9.3% | -88.5% |
| EPS (diluted) | $1.13 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $234.1M | $185.2M | ||
| Q3 25 | $222.2M | $169.1M | ||
| Q2 25 | $238.1M | $154.7M | ||
| Q1 25 | $222.2M | $125.2M | ||
| Q4 24 | $205.2M | $149.7M | ||
| Q3 24 | $208.4M | $141.5M | ||
| Q2 24 | $216.7M | $126.7M | ||
| Q1 24 | $196.3M | $110.4M |
| Q4 25 | $33.6M | $1.7M | ||
| Q3 25 | $35.1M | $17.3M | ||
| Q2 25 | $34.6M | $-24.4M | ||
| Q1 25 | $38.4M | $-21.7M | ||
| Q4 24 | $30.7M | $14.7M | ||
| Q3 24 | $32.0M | $-6.7M | ||
| Q2 24 | $33.1M | $-15.7M | ||
| Q1 24 | $29.1M | $-48.4M |
| Q4 25 | 39.7% | 85.7% | ||
| Q3 25 | 43.1% | 88.5% | ||
| Q2 25 | 41.1% | 90.2% | ||
| Q1 25 | 42.9% | 90.7% | ||
| Q4 24 | 40.3% | 90.1% | ||
| Q3 24 | 40.2% | 90.6% | ||
| Q2 24 | 39.4% | 91.1% | ||
| Q1 24 | 39.3% | 87.7% |
| Q4 25 | 18.4% | 8.6% | ||
| Q3 25 | 20.7% | 20.3% | ||
| Q2 25 | 18.8% | -6.1% | ||
| Q1 25 | 22.2% | -6.3% | ||
| Q4 24 | 19.1% | 10.7% | ||
| Q3 24 | 19.5% | 15.3% | ||
| Q2 24 | 19.2% | 11.8% | ||
| Q1 24 | 18.6% | -25.1% |
| Q4 25 | 14.3% | 0.9% | ||
| Q3 25 | 15.8% | 10.2% | ||
| Q2 25 | 14.5% | -15.8% | ||
| Q1 25 | 17.3% | -17.3% | ||
| Q4 24 | 15.0% | 9.8% | ||
| Q3 24 | 15.4% | -4.8% | ||
| Q2 24 | 15.3% | -12.4% | ||
| Q1 24 | 14.8% | -43.9% |
| Q4 25 | $1.13 | $0.00 | ||
| Q3 25 | $1.19 | $0.06 | ||
| Q2 25 | $1.17 | $-0.08 | ||
| Q1 25 | $1.30 | $-0.07 | ||
| Q4 24 | $1.04 | $0.05 | ||
| Q3 24 | $1.08 | $-0.02 | ||
| Q2 24 | $1.12 | $-0.05 | ||
| Q1 24 | $0.99 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $713.3M | $274.2M |
| Total Assets | $973.6M | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $293.5M | ||
| Q3 25 | — | $263.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | — | $249.8M | ||
| Q2 24 | — | $260.1M | ||
| Q1 24 | — | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $713.3M | $274.2M | ||
| Q3 25 | $702.5M | $230.4M | ||
| Q2 25 | $677.6M | $204.3M | ||
| Q1 25 | $641.7M | $193.6M | ||
| Q4 24 | $606.2M | $194.0M | ||
| Q3 24 | $591.2M | $178.8M | ||
| Q2 24 | $563.1M | $132.5M | ||
| Q1 24 | $535.6M | $130.7M |
| Q4 25 | $973.6M | $949.9M | ||
| Q3 25 | $978.3M | $868.8M | ||
| Q2 25 | $936.4M | $815.3M | ||
| Q1 25 | $899.6M | $789.8M | ||
| Q4 24 | $816.4M | $785.0M | ||
| Q3 24 | $802.9M | $786.6M | ||
| Q2 24 | $781.3M | $749.5M | ||
| Q1 24 | $743.5M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $54.8M | $16.3M |
| Free Cash FlowOCF − Capex | $50.8M | $16.0M |
| FCF MarginFCF / Revenue | 21.7% | 8.6% |
| Capex IntensityCapex / Revenue | 1.7% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.63× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $169.7M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $54.8M | $16.3M | ||
| Q3 25 | $51.3M | $35.7M | ||
| Q2 25 | $44.6M | $-26.5M | ||
| Q1 25 | $33.0M | $7.8M | ||
| Q4 24 | $52.1M | $-3.9M | ||
| Q3 24 | $45.1M | $-23.0M | ||
| Q2 24 | $36.4M | $22.7M | ||
| Q1 24 | $21.5M | $-29.7M |
| Q4 25 | $50.8M | $16.0M | ||
| Q3 25 | $48.2M | $35.3M | ||
| Q2 25 | $40.6M | $-28.9M | ||
| Q1 25 | $30.1M | $7.5M | ||
| Q4 24 | $47.4M | $-4.2M | ||
| Q3 24 | $42.0M | $-23.3M | ||
| Q2 24 | $34.1M | $21.6M | ||
| Q1 24 | $18.8M | $-31.5M |
| Q4 25 | 21.7% | 8.6% | ||
| Q3 25 | 21.7% | 20.9% | ||
| Q2 25 | 17.1% | -18.7% | ||
| Q1 25 | 13.5% | 6.0% | ||
| Q4 24 | 23.1% | -2.8% | ||
| Q3 24 | 20.1% | -16.5% | ||
| Q2 24 | 15.7% | 17.0% | ||
| Q1 24 | 9.6% | -28.5% |
| Q4 25 | 1.7% | 0.2% | ||
| Q3 25 | 1.4% | 0.2% | ||
| Q2 25 | 1.7% | 1.6% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 2.3% | 0.2% | ||
| Q3 24 | 1.5% | 0.3% | ||
| Q2 24 | 1.1% | 0.9% | ||
| Q1 24 | 1.4% | 1.6% |
| Q4 25 | 1.63× | 9.62× | ||
| Q3 25 | 1.46× | 2.06× | ||
| Q2 25 | 1.29× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 1.70× | -0.27× | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | 0.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BMI
| Transferred At Point In Time | $198.6M | 85% |
| Transferred Over Time | $22.1M | 9% |
| Other | $13.4M | 6% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
